Suchergebnisse - "Knapper, Steven"

PubPharm (4)

1

A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML

enthalten in: Blood | 2017

von Knapper, S. | Russell, N. | Gilkes, A. | +10

CommentIn: Blood. 2017 Mar 2;129(9):1061-1062. - PMID 28254820

2

FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo

enthalten in: Blood | 2011

von Sato, T. | Yang, X. | Knapper, S. | +6

CommentIn: Blood. 2011 Mar 24;117(12):3247-8. - PMID 21436074

3

A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy

enthalten in: Blood | 2006

von Knapper, S. | Burnett, A. | Littlewood, T. | +6

4

The effects of lestaurtinib (CEP701) and PKC412 on primary AML blasts : the induction of cytotoxicity varies with dependence on FLT3 signaling in both FLT3-mutated and wild-type cases

enthalten in: Blood | 2006

von Knapper, S. | Mills, K. | Gilkes, A. | +3

1
[1]